CDK2 inhibition produces a persistent population of polyploid cancer cells

Liliya Tyutyunyk-Massey1, Zibo Chen1, Xiuxia Liu1

  • 1Molecular Pharmacology Program and.

JCI Insight
|April 15, 2025
PubMed

Insights

Targeting cyclin-dependent kinase 2 (CDK2) causes cancer cell death, but some polyploid cells survive. Combined CDK2 and CDK1 or kinesin inhibition may eliminate resistant cancer cells.

Area of Science:

  • Oncology
  • Cell Biology
  • Genetics

Background:

  • Aneuploidy is a hallmark of cancer, contributing to chromosomal instability, drug resistance, and aggressive tumor progression.
  • Cyclin-dependent kinase 2 (CDK2) plays a critical role in cell cycle regulation and is implicated in cancer development.

Purpose of the Study:

  • To investigate the effects of CDK2 inhibition on aneuploid cancer cells and identify mechanisms of resistance.
  • To explore potential therapeutic strategies for overcoming resistance to CDK2 inhibition in lung cancer.

Main Methods:

  • Utilized time-lapse fluorescence microscopy with FUCCI probes to observe cell division dynamics in aneuploid lung cancer cells after CDK2 inhibition.
  • Performed RNA-Seq analysis to identify molecular pathways affected by CDK2 inhibition in different ploidy states.
  • Analyzed The Cancer Genome Atlas (TCGA) data to correlate CDK1 and KIF family member expression with patient survival.
  • Employed intravital microscopy to validate in vitro findings in a mouse model of lung cancer.

Main Results:

  • CDK2 inhibition induced anaphase catastrophe and apoptosis in aneuploid cells with supernumerary centrosomes.
  • A subset of polyploid cancer cells survived CDK2 inhibition, exhibiting resistance to apoptosis and continued proliferation.
  • RNA-Seq and TCGA analyses revealed enrichment of CDK1 and KIF pathways, with their overexpression linked to poor survival in lung cancer.
  • In vivo studies confirmed the emergence of apoptosis-resistant polyploid cancer cells following CDK2 inhibition in mice.

Conclusions:

  • CDK2 inhibition can trigger cell death in aneuploid cancer cells but leads to the selection of resistant polyploid populations.
  • Combined targeting of CDK2 with CDK1 or kinesin family members presents a promising therapeutic strategy to eliminate resistant polyploid cancer cells.
  • These findings have translational relevance for developing novel anti-cancer treatments for aggressive lung cancers.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
4.6K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K